Xilio Therapeutics
29 hedge funds and large institutions have $48.3M invested in Xilio Therapeutics in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 9 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
57% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 7
67% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 9
Holders
29
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$7.06M | |
| 2 | +$1.37M | |
| 3 | +$221K | |
| 4 |
CC
Cannell Capital
Alta,
Wyoming
|
+$36.7K |
| 5 |
NL
NWAM LLC
Mercer Island,
Washington
|
+$29K |
Top Sellers
| 1 | -$6.07M | |
| 2 | -$4.82M | |
| 3 | -$878K | |
| 4 |
Norges Bank
Oslo,
Norway
|
-$356K |
| 5 |
Renaissance Technologies
New York
|
-$136K |